ASCO专区
- 09-09-30CURRENT STANDARD PRACTICE AFTER ASCO 2009: NSCLC
- 09-09-30卵巢上皮癌治疗及进展
- 09-09-30维持治疗和生物标志物——能否转化为临床实践？
- 09-09-30Advances in first-line treatment of non-small ce ...
- 09-09-30Molecular and clinical predictors of outcome for ...
- 09-09-30Maintenance pemetrexed (Pem) plus best suppor ...
- 09-09-30Biomarker analyses from a phase III randomized op ...
- 09-09-30Discussion Lung Cancer Session II
- 09-09-30A randomized double-blind placebo-controll ...
- 09-09-30Discussion Lung Cancer Session I
- 09-09-30Non-small cell lung cancer and estrogen plus prog ...
- 09-09-30Surgery (S) alone preoperative (preop) paclita ...
- 09-09-302009 ASCO 报道——卵巢癌化疗进展
- 09-09-30A phase III study comparing concurrent gemcitab ...
- 09-09-30A randomized trial in ovarian cancer (OC) of early tr ...
- 09-09-30A randomized phase III study (AGO-OVAR-9 GINECO- ...
- 09-09-30A randomized phase III study of carboplatin and peg ...
- 09-09-30Carboplatin plus paclitaxel (CP) versus carbo ...
- 09-09-30SMALL STEPS: IMPORTANT ADVANCES IN LESS COMMON TU ...
- 09-09-29ESPAC-3(v2): A multicenter international open ...
- 09-09-29Placebo-controlled double-blind prospect ...
- 09-09-29Gemcitabine with or without cisplatin in patien ...
- 09-09-29非霍奇金淋巴瘤的诊治新进展
- 09-09-29Optimizing biologic therapy in the adjuvant set ...
- 09-09-29A randomized trial of chemoradiation using mito ...
- 09-09-29Neoadjuvant chemotherapy versus surgery alo ...
- 09-09-29Efficacy results from the ToGA trial: A phase III stu ...
- 09-09-29ASCO精选（2009)
- 09-09-29Microsatellite instability (MSI) in stage II and ...
- 09-09-29A phase III trial assessing bevacizumab in stage II a ...
- 09-09-29Results of the Prodige 2-ACCORD 12/0405 Randomiz ...
- 09-09-29Complete remissions with weekly dosing of SGN-35 a ...
- 09-09-29R-ICE versus R-DHAP in relapsed patients with CD20 d ...
- 09-09-29A phase III trial comparing R-CHOP 14 and R-CHOP 21 for the ...
- 09-09-29Idiotype vaccine therapy (BiovaxID) in follic ...
- 09-09-29Breast Cancer: New Drug Therapies
- 09-09-29Best of ASCO 2009
- 09-09-29A phase II study of trastuzumab-DM1 (T-DM1) a HER2 ant ...
- 09-09-29Phase II trial of the oral PARP inhibitor olaparib in B ...
- 09-09-29Efficacy of BSI-201 a poly (ADP-ribose) polymera ...
- 09-09-29Breast Cancer - Metastatic
- 09-09-29Phase III trial comparing 4-cycle doxorubicin p ...
- 09-09-29Value of adjuvant radiation therapy in breast can ...
- 09-09-29Impact of omission of completion axillary lymph n ...
- 09-09-29Breast Cancer: BEST OF ASCO IN CHINA 2009
- 09-09-29Phase III trial comparing 4-cycle doxorubicin p ...
- 09-09-29Value of adjuvant radiation therapy in breast can ...
- 09-09-29Impact of omission of completion axillary lymph n ...